Status and phase
Conditions
Treatments
About
Single arms prospective phase II study of SBRT for oligometastatases from colorectal cancer
Full description
Single arms prospective phase II study of SBRT for oligometastatases from colorectal cancer, the primary concerns are treatment efficacy and toxicities.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
18-75 years
Eastern Cooperative Oncology Group (ECOG) performance score ≤ 1
Diagnosis by pathological examination
Primary lesion is under control by surgery
Adequate blood counts:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
50 participants in 1 patient group
Loading...
Central trial contact
Jing Jin, Doctor; Ning Li, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal